Figure 1.
NIRF targeted imaging of human platelets and competitive inhibition studies. (A) In vitro binding affinity of TIRO-CyAl5.5 to human platelets as obtained by FRI. (B) NIRF signal was significantly blocked with an excess of competitor Tirofiban. *P < 0.05, **P < 0.001.